US Patent Issued to PRECISION BIOLOGICS on April 21 for "Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer" (New York, Maryland Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,621, issued on April 21, was assigned to PRECISION BIOLOGICS INC. (Bethesda, Md.).

"Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer" was invented by Xue-Ping Wang (Port Washington, N.Y.) and Philip M. Arlen (Bethesda, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to humanized antibodies that selectively bind the 31.1 epitope on the A33 protein differentially expressed in cancers including, lung cancer, ovarian cancer, pancreas cancer, breast cancer, and colon cancer, and diagnostic and therapeutic usages."

The patent was filed on Oct. 20, 2022, under Applic...